US equities
|
INTC
$112.50
▲+0.00%
MU
$1,045.56
▲+0.00%
SNDK
$1,660.46
▲+0.00%
NVDA
$239.24
▲+0.00%
SPCX
$171.92
▲+0.00%
MRVL
$287.01
▲+0.00%
AMD
$649.42
▲+0.00%
MSTR
$164.55
▲+0.00%
INTC
$112.50
▲+0.00%
MU
$1,045.56
▲+0.00%
SNDK
$1,660.46
▲+0.00%
NVDA
$239.24
▲+0.00%
SPCX
$171.92
▲+0.00%
MRVL
$287.01
▲+0.00%
AMD
$649.42
▲+0.00%
MSTR
$164.55
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about Josh Bartch
Recent news which mentions Josh Bartch
Psychedelic-Based Drugs Biotech Company Begins Trading On UK's AQSE Growth Market
October 12, 2023
Tickers
MYCOF
Tags
Josh Bartch
Cannabis
MYCOF
From
Benzinga
Two Psychedelic Companies File Patent Applications For Psilocybin And MDMA Analogues, Here's What Could Change
July 19, 2022
Tickers
LOBEF
MYCOF
Tags
Dr/ Rakesh Jetly
Rob Roscow
Market News
From
Benzinga
Government-Funded Smoking Cessation Trial Uses Mydecine's New Psilocybin-Derived MYCO-001, Recently FDA-Approved
June 17, 2022
Tickers
MYCOF
Tags
News
FDA
Benzinga
From
Benzinga